Meeder Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-26
| Closed | -$1.66K | – | 1000 |
|
2025
Q1 | $1.66K | Sell |
26
-6
| -19% | -$383 | ﹤0.01% | 876 |
|
2024
Q4 | $3.89K | Sell |
32
-514
| -94% | -$62.5K | ﹤0.01% | 859 |
|
2024
Q3 | $68.2K | Buy |
546
+21
| +4% | +$2.62K | ﹤0.01% | 328 |
|
2024
Q2 | $83K | Buy |
525
+492
| +1,491% | +$77.7K | 0.01% | 278 |
|
2024
Q1 | $4.27K | Buy |
+33
| New | +$4.27K | ﹤0.01% | 650 |
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 2359 |
|
2022
Q2 | $0 | Sell |
4
-22
| -85% | – | ﹤0.01% | 2419 |
|
2022
Q1 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 2080 |
|
2021
Q4 | – | Sell |
-14
| Closed | -$1K | – | 2186 |
|
2021
Q3 | $1K | Sell |
14
-4
| -22% | -$286 | ﹤0.01% | 2372 |
|
2021
Q2 | $1K | Sell |
18
-1
| -5% | -$56 | ﹤0.01% | 2392 |
|
2021
Q1 | $1K | Sell |
19
-17
| -47% | -$895 | ﹤0.01% | 2263 |
|
2020
Q4 | $6K | Buy |
36
+1
| +3% | +$167 | ﹤0.01% | 1174 |
|
2020
Q3 | $5K | Sell |
35
-7
| -17% | -$1K | ﹤0.01% | 1593 |
|
2020
Q2 | $7K | Sell |
42
-25
| -37% | -$4.17K | ﹤0.01% | 1437 |
|
2020
Q1 | $7K | Sell |
67
-5
| -7% | -$522 | ﹤0.01% | 1671 |
|
2019
Q4 | $9K | Buy |
72
+45
| +167% | +$5.63K | ﹤0.01% | 1597 |
|
2019
Q3 | $2K | Sell |
27
-202
| -88% | -$15K | ﹤0.01% | 1984 |
|
2019
Q2 | $35K | Sell |
229
-4,980
| -96% | -$761K | ﹤0.01% | 1055 |
|
2019
Q1 | $620K | Buy |
5,209
+2,644
| +103% | +$315K | 0.05% | 343 |
|
2018
Q4 | $281K | Buy |
2,565
+2,416
| +1,621% | +$265K | 0.03% | 430 |
|
2018
Q3 | $24K | Sell |
149
-272
| -65% | -$43.8K | ﹤0.01% | 984 |
|
2018
Q2 | $55.6K | Buy |
+421
| New | +$55.6K | ﹤0.01% | 731 |
|
2018
Q1 | – | Sell |
-30
| Closed | -$2K | – | 1732 |
|
2017
Q4 | $2K | Sell |
30
-44
| -59% | -$2.93K | ﹤0.01% | 1505 |
|
2017
Q3 | $3K | Buy |
+74
| New | +$3K | ﹤0.01% | 1386 |
|
2017
Q2 | – | Sell |
-103
| Closed | -$3K | – | 1852 |
|
2017
Q1 | $3K | Buy |
+103
| New | +$3K | ﹤0.01% | 1280 |
|